Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)
<p style="text-align:justify;"> <b>Background:</b> Diffuse large B-cell lymphoma (DLBCL) comprises 31% of lymphomas in the United States. Although it is an aggressive type of lymphoma, 40% to 50% of patients are cured with treatment. The study objectives were to identify...
Main Authors: | Griffiths, R, Gleeson, M, Knopf, K, Danese, M |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
BioMed Central
2010
|
פריטים דומים
-
Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)
מאת: Gleeson Michelle, et al.
יצא לאור: (2010-11-01) -
Second-line therapy in diffuse large B-cell lymphoma (DLBCL): treatment patterns and outcomes in older patients receiving outpatient chemotherapy.
מאת: Danese, MD, et al.
יצא לאור: (2016) -
Retrospective Evaluation of Patients Diagnosed with Diffuse Large B Cell Lymphoma (DLBCL)
מאת: Atakan TEKİNALP, et al.
יצא לאור: (2020-12-01) -
Survival in elderly follicular lymphoma patients who receive frontline chemo-immunotherapy.
מאת: Griffiths, R, et al.
יצא לאור: (2010) -
Interleukin 10 gene promoter polymorphism and risk of diffuse large B cell lymphoma (DLBCL)
מאת: Roba M. Talaat, et al.
יצא לאור: (2014-01-01)